EUVIMEDEUVIMED entdecken
Open Access

The Silent Face of Chronic Hepatitis B: Biopsy-Supported Fibrosis Detection and the Reliability of Non-Invasive Scores (FIB-4, APRI) in Inactive, Gray Zone, and Immune-Tolerant Cases

Mehmet Kasım Aydın iD

Medical Science Monitor · 2025

DOI: 10.12659/msm.951084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Mehmet Kasım Aydın. Beteiligte Einrichtung: Department of Gastroenterology, Faculty of Medicine, Mersin University, Mersin, Turkey. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Liver Cirrhosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicLiver CirrhosisHumansFemaleMaleAdultAspartate AminotransferasesRetrospective StudiesMiddle AgedBiopsyCross-Sectional StudiesROC CurveLiverReproducibility of ResultsPlatelet CountImmune ToleranceSeverity of Illness Index

Substanzen

Aspartate Aminotransferases

Autor:innen und Institutionen

  • Department of Gastroenterology, Faculty of Medicine, Mersin University, Mersin, Turkey.

ORCID-Profile: Mehmet Kasım Aydın

Zitieren

APA

Aydın, M. K. (2025). The Silent Face of Chronic Hepatitis B: Biopsy-Supported Fibrosis Detection and the Reliability of Non-Invasive Scores (FIB-4, APRI) in Inactive, Gray Zone, and Immune-Tolerant Cases. Medical Science Monitor. https://doi.org/10.12659/msm.951084

Vancouver

Aydın MK. The Silent Face of Chronic Hepatitis B: Biopsy-Supported Fibrosis Detection and the Reliability of Non-Invasive Scores (FIB-4, APRI) in Inactive, Gray Zone, and Immune-Tolerant Cases. Medical Science Monitor. 2025. doi:10.12659/msm.951084

BibTeX
@article{Aydn2025,
  author = {Aydın, Mehmet Kasım},
  title = {The Silent Face of Chronic Hepatitis B: Biopsy-Supported Fibrosis Detection and the Reliability of Non-Invasive Scores (FIB-4, APRI) in Inactive, Gray Zone, and Immune-Tolerant Cases},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.951084}
}
Kostenlos starten →